Abubacar, Zayd .
HRN: 22-25-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2022
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
11/27/2022
12/03/2022
PO
3.9 Ml
Q12
T/C UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes